Schedule 13G ownership disclosure

MILESTONE PHARMACEUTICALS IN

Security class unavailable · CUSIP: 59935V107

Event date: 2019-05-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-19-007825
Form type
SC 13G
Filer
Milestone Pharmaceuticals Inc.
CIK
CIK 1408443
Filed
May 20, 2019
Reporting period
May 09, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub